SHIKARI® Q-OMA
The Matriks Biotek Omalizumab ELISA has been specially developed for the quantitative analysis Omalizumab in serum and plasma samples between the Cmin and Cmax range of concentrations (indicated in the pharmacokinetics section of protocol linked below).
SHIKARI® S-ATO
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
5ul
70 min
Serum, plasma
96
10ng/mL
85-115%
1 year
The Matriks Biotek anti-Omalizumab (Xolair®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Omalizumab (Xolair®) in serum and plasma. It is for professional use only.
Calibration Curve
SHIKARI® Q-OMA & S-ATO
Omalizumab (Xolair®)
Enzyme immunoassay for the quantitative determination of Omalizumab (Xolair®) in serum and plasma
Enzyme immunoassay for the qualitative determination (screening) of Omalizumab (Xolair®) in serum and plasma
Required Volume
Total Time
Sample
Sample Number
Detection Limit
Spike Recovery
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
OMA-FD-XOL: $910.00 Lead time: 1-2 weeks
OMA-QLS-XOL: $910.00 Lead time: 1-2 weeks
 | ||||
.....................................................
.....................................................
Drug Measurement
Anti-drug Antibody Measurement
Quantitative
Qualitative
Omalizumab (Xolair®)
Allergy Drugs
Iwai North America Inc.
541 Taylor Way Suite# 4
San Carlos, CA 94070
Phone : (650) 486-1541
Fax : (650) 394-8638
Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................
